0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Intravenous Solutions Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031
Published Date: May 2025
|
Report Code: QYRE-Auto-7246
Home | Market Reports | Health| Pharmacy| Drugs & Medications
Global Intravenous Solutions Market Insights and Forecast to 2028
BUY CHAPTERS

Global Intravenous Solutions Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031

Code: QYRE-Auto-7246
Report
May 2025
Pages:125
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Intravenous Solutions Market Size

In 2024, the global market size of Intravenous Solutions was estimated to be worth US$ 12420 million and is forecast to reach approximately US$ 18930 million by 2031 with a CAGR of 6.3% during the forecast period 2025-2031.

Intravenous Solutions Market

Intravenous Solutions Market

Intravenous Solutions is the infusion of liquid substances directly into a vein. Therapies administered intravenously are often included in the designation of specialty drugs. Intravenous infusions are commonly referred to as drips because many systems of administration employ a drip chamber, which prevents air from entering the blood stream (air embolism), and allows an estimation of flow rate.
Global Intravenous Solutions key players include Baxter, Kelun Group, Fresenius Kabi, etc. Global top three manufacturers hold a share over 35%.
Asia-Pacific is the largest market, with a share over 45%, followed by Europe, and North America, both have a share over 40 percent.
In terms of product, Crystalloids is the largest segment, with a share over 75%. And in terms of application, the largest application is Basic IV Solutions, followed by Nutrient Infusion Solution, etc.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Intravenous Solutions, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Intravenous Solutions.
The Intravenous Solutions market size, estimations, and forecasts are provided in terms of sales volume (M Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Intravenous Solutions market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Intravenous Solutions manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and regions.

Scope of Intravenous Solutions Market Report

Report Metric Details
Report Name Intravenous Solutions Market
Forecasted market size in 2031 approximately US$ 18930 million
CAGR 6.3%
Forecasted years 2025 - 2031
Segment by Type
  • Crystalloids
  • Colloids
  • Others
Segment by Application
  • Basic IV Solutions
  • Nutrient Infusion Solution
  • Others
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Baxter, Kelun Group, Fresenius Kabi, Otsuka, ICU Medical, JW Life Science, B. Braun Melsungen
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Sales (consumption), revenue of Intravenous Solutions in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
  • Chapter 3: Detailed analysis of Intravenous Solutions manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Intravenous Solutions sales, revenue, price, gross margin, sales by region, by Type, by Application, and recent development, etc.
  • Chapter 5: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 6: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 7: North America by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 8: APAC by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 9: Europe by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 10: Latin America by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 11: Middle East and Africa by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
  • Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 14: Research Findings and Conclusion.

FAQ for this report

What is the Intravenous Solutions Market size in 2031?

Ans: The Intravenous Solutions Market size in 2031 will be approximately US$ 18930 million.

What is the market share of major companies in Intravenous Solutions Market?

Ans: Global top three manufacturers hold a share over 35%.

What is the Intravenous Solutions Market share by type?

Ans: In terms of product, Crystalloids is the largest segment, with a share over 75%.

Who are the main players in the Intravenous Solutions Market report?

Ans: The main players in the Intravenous Solutions Market are Baxter, Kelun Group, Fresenius Kabi, Otsuka, ICU Medical, JW Life Science, B. Braun Melsungen

What are the Application segmentation covered in the Intravenous Solutions Market report?

Ans: The Applications covered in the Intravenous Solutions Market report are Basic IV Solutions, Nutrient Infusion Solution, Others

What are the Type segmentation covered in the Intravenous Solutions Market report?

Ans: The Types covered in the Intravenous Solutions Market report are Crystalloids, Colloids, Others

Recommended Reports

IV Solutions Devices

Infusion Set Components

Advanced Infusion Systems

Market trends :

Topic Trends
Global the global intravenous solutions market is experiencing robust growth driven by increasing demand for basic iv solutions and nutrient infusion solutions, with asia-pacific leading expansion due to rising healthcare infrastructure and patient needs.
Type Crystalloids - crystalloids continue to dominate the intravenous solutions market, accounting for over 75% share due to their widespread use in hospitals and emergency care settings.
Colloids - colloids maintain a stable presence in the intravenous solutions market, primarily utilized for specific clinical indications where fluid resuscitation is required.
Application Basic IV Solutions - basic iv solutions remain the largest application segment, driven by their essential role in routine patient care and increasing global hospitalization rates.
Nutrient Infusion Solution - nutrient infusion solutions are gaining traction as hospitals and clinics focus on improving patient nutrition and recovery outcomes.
Region APAC - asia-pacific leads the intravenous solutions market with over 45% share, fueled by expanding healthcare infrastructure and rising patient populations.
Europe - europe maintains strong demand for intravenous solutions, supported by advanced healthcare systems and increasing adoption of nutrient infusion therapies.
North America - north america continues to see steady growth in intravenous solutions usage, driven by high healthcare expenditure and technological advancements.
LATAM - latin america is witnessing gradual growth in intravenous solutions adoption as healthcare access and infrastructure improve across key countries.
1 Study Coverage
1.1 Intravenous Solutions Product Introduction
1.2 Market by Type
1.2.1 Global Intravenous Solutions Market Size Growth Rate by Type (2020 VS 2024 VS 2031)
1.2.2 Crystalloids
1.2.3 Colloids
1.2.4 Others
1.3 Market by Application
1.3.1 Global Intravenous Solutions Market Size Growth Rate by Application (2020 VS 2024 VS 2031)
1.3.2 Basic IV Solutions
1.3.3 Nutrient Infusion Solution
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Intravenous Solutions Market Size Estimates and Forecasts
2.1.1 Global Intravenous Solutions Revenue 2020-2031
2.1.2 Global Intravenous Solutions Sales 2020-2031
2.2 Intravenous Solutions Market Size by Region: 2024 Versus 2031
2.3 Intravenous Solutions Sales by Region (2020-2031)
2.3.1 Global Intravenous Solutions Sales by Region: 2020-2025
2.3.2 Global Intravenous Solutions Sales Forecast by Region (2026-2031)
2.3.3 Global Intravenous Solutions Sales Market Share by Region (2020-2031)
2.4 Intravenous Solutions Market Estimates and Projections by Region (2026-2031)
2.4.1 Global Intravenous Solutions Revenue by Region: 2020-2025
2.4.2 Global Intravenous Solutions Revenue Forecast by Region (2026-2031)
2.4.3 Global Intravenous Solutions Revenue Market Share by Region (2020-2031)
3 Market Segments
3.1 Breakdown Data by Type
3.1.1 Global Intravenous Solutions Sales by Type (2020-2031)
3.1.1.1 Global Intravenous Solutions Sales Volume by Type (2020-2031)
3.1.1.2 Global Intravenous Solutions Sales Market Share by Type (2020-2031)
3.1.2 Global Intravenous Solutions Revenue by Type (2020-2031)
3.1.2.1 Global Intravenous Solutions Revenue by Type (2020-2031)
3.1.2.2 Global Intravenous Solutions Revenue Market Share by Type (2020-2031)
3.1.3 Intravenous Solutions Average Selling Price (ASP) by Type (2020-2031)
3.2 Breakdown Data by Application
3.2.1 Global Intravenous Solutions Sales by Application (2020-2031)
3.2.1.1 Global Intravenous Solutions Sales Volume by Application (2020-2031)
3.2.1.2 Global Intravenous Solutions Sales Market Share by Application (2020-2031)
3.2.2 Global Intravenous Solutions Revenue by Application (2020-2031)
3.2.2.1 Global Intravenous Solutions Revenue by Application (2020-2031)
3.2.2.2 Global Intravenous Solutions Revenue Market Share by Application (2020-2031)
3.2.3 Intravenous Solutions Average Selling Price (ASP) by Application (2020-2031)
3.3 by Type and by Application Crossing Analysis
3.3.1 Crystalloids of Intravenous Solutions Revenue Market Share by Application
3.3.2 Colloids of Intravenous Solutions Revenue Market Share by Application
3.3.3 Others of Intravenous Solutions Revenue Market Share by Application
4 Global Intravenous Solutions by Manufacturers
4.1 Global Top Intravenous Solutions Manufacturers by Sales (2020-2025)
4.1.1 Global Intravenous Solutions Sales by Manufacturer (2020-2025)
4.1.2 Global Intravenous Solutions Sales Market Share by Manufacturer (2020-2025)
4.2 Global Top Intravenous Solutions Manufacturers by Revenue (2020-2025)
4.2.1 Global Intravenous Solutions Revenue by Manufacturer (2020-2025)
4.2.2 Global Intravenous Solutions Revenue Share by Manufacturer (2020-2025)
4.3 Global Intravenous Solutions Price by Manufacturer (2020-2025)
4.4 Competitive Landscape
4.4.1 Key Intravenous Solutions Manufacturers Covered: Ranking by Revenue
4.4.2 Global Intravenous Solutions Market Concentration Ratio (CR5 and HHI) & (2020-2025)
4.4.3 Global Intravenous Solutions Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.5 Global Intravenous Solutions Manufacturing Base Distribution, Product Type
4.5.1 Intravenous Solutions Manufacturers Manufacturing Base Distribution, Headquarters
4.5.2 Date of International Manufacturers Enter into Intravenous Solutions Market
4.5.3 Manufacturers Intravenous Solutions Product Type and Application
4.5.4 Crystalloids Market Sales of Intravenous Solutions by Manufacturer
4.5.5 Colloids Market Sales of Intravenous Solutions by Manufacturer
4.5.6 Others Market Sales of Intravenous Solutions by Manufacturer
4.6 Manufacturers Mergers & Acquisitions, Expansion Plans
5 Company Profiles
5.1 Baxter
5.1.1 Baxter Company Information
5.1.2 Baxter Description, Business Overview
5.1.3 Baxter Intravenous Solutions Products Offered
5.1.4 Baxter Intravenous Solutions Sales, Revenue and Gross Margin (2020-2025)
5.1.5 Baxter Intravenous Solutions Sales by Product in 2024
5.1.6 Baxter Intravenous Solutions Sales by Application in 2024
5.1.7 Baxter Intravenous Solutions Sales by Geographic Area in 2024
5.1.8 Baxter Recent Developments
5.2 Kelun Group
5.2.1 Kelun Group Company Information
5.2.2 Kelun Group Description, Business Overview
5.2.3 Kelun Group Intravenous Solutions Products Offered
5.2.4 Kelun Group Intravenous Solutions Sales, Revenue and Gross Margin (2020-2025)
5.2.5 Kelun Group Intravenous Solutions Sales by Product in 2024
5.2.6 Kelun Group Intravenous Solutions Sales by Application in 2024
5.2.7 Kelun Group Intravenous Solutions Sales by Geographic Area in 2024
5.2.8 Kelun Group Recent Developments
5.3 Fresenius Kabi
5.3.1 Fresenius Kabi Company Information
5.3.2 Fresenius Kabi Description, Business Overview
5.3.3 Fresenius Kabi Intravenous Solutions Products Offered
5.3.4 Fresenius Kabi Intravenous Solutions Sales, Revenue and Gross Margin (2020-2025)
5.3.5 Fresenius Kabi Intravenous Solutions Sales by Product in 2024
5.3.6 Fresenius Kabi Intravenous Solutions Sales by Application in 2024
5.3.7 Fresenius Kabi Intravenous Solutions Sales by Geographic Area in 2024
5.3.8 Fresenius Kabi Recent Developments
5.4 Otsuka
5.4.1 Otsuka Company Information
5.4.2 Otsuka Description, Business Overview
5.4.3 Otsuka Intravenous Solutions Products Offered
5.4.4 Otsuka Intravenous Solutions Sales, Revenue and Gross Margin (2020-2025)
5.4.5 Otsuka Intravenous Solutions Sales by Product in 2024
5.4.6 Otsuka Intravenous Solutions Sales by Application in 2024
5.4.7 Otsuka Intravenous Solutions Sales by Geographic Area in 2024
5.4.8 Otsuka Recent Developments
5.5 ICU Medical
5.5.1 ICU Medical Company Information
5.5.2 ICU Medical Description, Business Overview
5.5.3 ICU Medical Intravenous Solutions Products Offered
5.5.4 ICU Medical Intravenous Solutions Sales, Revenue and Gross Margin (2020-2025)
5.5.5 ICU Medical Intravenous Solutions Sales by Product in 2024
5.5.6 ICU Medical Intravenous Solutions Sales by Application in 2024
5.5.7 ICU Medical Intravenous Solutions Sales by Geographic Area in 2024
5.5.8 ICU Medical Recent Developments
5.6 Fresenius Kabi
5.6.1 Fresenius Kabi Company Information
5.6.2 Fresenius Kabi Description, Business Overview
5.6.3 Fresenius Kabi Intravenous Solutions Products Offered
5.6.4 Fresenius Kabi Intravenous Solutions Sales, Revenue and Gross Margin (2020-2025)
5.6.5 Fresenius Kabi Intravenous Solutions Sales by Product in 2024
5.6.6 Fresenius Kabi Intravenous Solutions Sales by Application in 2024
5.6.7 Fresenius Kabi Intravenous Solutions Sales by Geographic Area in 2024
5.6.8 Fresenius Kabi Recent Developments
5.7 JW Life Science
5.7.1 JW Life Science Company Information
5.7.2 JW Life Science Description, Business Overview
5.7.3 JW Life Science Intravenous Solutions Products Offered
5.7.4 JW Life Science Intravenous Solutions Sales, Revenue and Gross Margin (2020-2025)
5.7.5 JW Life Science Intravenous Solutions Sales by Product in 2024
5.7.6 JW Life Science Intravenous Solutions Sales by Application in 2024
5.7.7 JW Life Science Intravenous Solutions Sales by Geographic Area in 2024
5.7.8 JW Life Science Recent Developments
5.8 B. Braun Melsungen
5.8.1 B. Braun Melsungen Company Information
5.8.2 B. Braun Melsungen Description, Business Overview
5.8.3 B. Braun Melsungen Intravenous Solutions Products Offered
5.8.4 B. Braun Melsungen Intravenous Solutions Sales, Revenue and Gross Margin (2020-2025)
5.8.5 B. Braun Melsungen Intravenous Solutions Sales by Product in 2024
5.8.6 B. Braun Melsungen Intravenous Solutions Sales by Application in 2024
5.8.7 B. Braun Melsungen Intravenous Solutions Sales by Geographic Area in 2024
5.8.8 B. Braun Melsungen Recent Developments
6 North America
6.1 North America Intravenous Solutions Market Size YoY Growth 2020-2031
6.2 North America Intravenous Solutions Market Facts & Figures by Country
6.2.1 North America Intravenous Solutions Sales by Country (2020-2031)
6.2.2 North America Intravenous Solutions Revenue by Country (2020-2031)
6.3 North America Intravenous Solutions Sales by Type (2020-2025)
6.4 North America Intravenous Solutions Sales by Application (2020-2025)
7 Asia-Pacific
7.1 Asia-Pacific Intravenous Solutions Market Size YoY Growth 2020-2031
7.2 Asia-Pacific Intravenous Solutions Market Facts & Figures by Region
7.2.1 Asia-Pacific Intravenous Solutions Sales by Region (2020-2031)
7.2.2 Asia-Pacific Intravenous Solutions Revenue by Region (2020-2031)
7.3 Asia-Pacific Intravenous Solutions Sales by Type (2020-2025)
7.4 Asia-Pacific Intravenous Solutions Sales by Application (2020-2025)
8 Europe
8.1 Europe Intravenous Solutions Market Size YoY Growth 2020-2031
8.2 Europe Intravenous Solutions Market Facts & Figures by Country
8.2.1 Europe Intravenous Solutions Sales by Country (2020-2031)
8.2.2 Europe Intravenous Solutions Revenue by Country (2020-2031)
8.3 Europe Intravenous Solutions Sales by Type (2020-2025)
8.4 Europe Intravenous Solutions Sales by Application (2020-2025)
9 Latin America
9.1 Latin America Intravenous Solutions Market Size YoY Growth 2020-2031
9.2 Latin America Intravenous Solutions Market Facts & Figures by Country
9.2.1 Latin America Intravenous Solutions Sales by Country (2020-2031)
9.2.2 Latin America Intravenous Solutions Revenue by Country (2020-2031)
9.3 Latin America Intravenous Solutions Sales by Type (2020-2025)
9.4 Latin America Intravenous Solutions Sales by Application (2020-2025)
10 Middle East and Africa
10.1 Latin America Intravenous Solutions Market Size YoY Growth 2020-2031
10.2 Middle East and Africa Intravenous Solutions Market Facts & Figures by Country
10.2.1 Middle East and Africa Intravenous Solutions Sales by Country (2020-2031)
10.2.2 Middle East and Africa Intravenous Solutions Revenue by Country (2020-2031)
10.3 Middle East and Africa Intravenous Solutions Sales by Type (2020-2025)
10.4 Middle East and Africa Intravenous Solutions Sales by Application (2020-2025)
11 Supply Chain and Sales Channel analysis
11.1 Intravenous Solutions Supply Chain Analysis
11.2 Intravenous Solutions Key Raw Materials and Upstream Suppliers
11.3 Intravenous Solutions Clients Analysis
11.4 Intravenous Solutions Sales Channel and Sales Model Analysis
11.4.1 Intravenous Solutions Distribution Channel Analysis: Indirect Sales VS Direct Sales
11.4.2 Intravenous Solutions Distribution Channel Analysis: Online Sales VS Offline Sales
11.4.3 Intravenous Solutions Distributors
12 Intravenous Solutions Market Dynamics
12.1 Intravenous Solutions Industry Trends
12.2 Intravenous Solutions Market Drivers
12.3 Intravenous Solutions Market Challenges
12.4 Intravenous Solutions Market Restraints
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
List of Tables
 Table 1. Global Intravenous Solutions Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Global Intravenous Solutions Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 3. Global Intravenous Solutions Market Size by Region (US$ Million): 2024 VS 2031
 Table 4. Global Intravenous Solutions Sales by Region (2020-2025) & (M Units)
 Table 5. Global Intravenous Solutions Sales Forecast by Region (2026-2031) & (M Units)
 Table 6. Global Intravenous Solutions Revenue by Region (2020-2025) & (US$ Million)
 Table 7. Global Intravenous Solutions Revenue Forecast by Region (2026-2031) & (US$ Million)
 Table 8. Global Intravenous Solutions Sales Volume by Type (2020-2025) & (M Units)
 Table 9. Global Intravenous Solutions Sales Volume by Type (2026-2031) & (M Units)
 Table 10. Global Intravenous Solutions Revenue by Type (2020-2025) & (US$ Million)
 Table 11. Global Intravenous Solutions Revenue Forecast by Type (2026-2031) & (US$ Million)
 Table 12. Global Intravenous Solutions Sales Volume by Application (2020-2025) & (M Units)
 Table 13. Global Intravenous Solutions Sales Volume by Application (2026-2031) & (M Units)
 Table 14. Global Intravenous Solutions Revenue by Application (2020-2025) & (US$ Million)
 Table 15. Global Intravenous Solutions Revenue by Application (2026-2031) & (US$ Million)
 Table 16. Global Intravenous Solutions Sales by Manufacturer (2020-2025) & (M Units)
 Table 17. Global Intravenous Solutions Sales Share by Manufacturer (2020-2025)
 Table 18. Intravenous Solutions Revenue by Manufacturer (2020-2025) & (US$ Million)
 Table 19. Intravenous Solutions Revenue Share by Manufacturer (2020-2025)
 Table 20. Key Manufacturers Intravenous Solutions Price (2020-2025) & (USD/K Unit)
 Table 21. Ranking of Global Top Intravenous Solutions Manufacturers by Revenue (US$ Million) in 2024
 Table 22. Global Intravenous Solutions Manufacturers Market Concentration Ratio (CR5 and HHI) & (2020-2025)
 Table 23. Global Intravenous Solutions by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Intravenous Solutions as of 2024)
 Table 24. Intravenous Solutions Manufacturers Manufacturing Base Distribution and Headquarters
 Table 25. Date of International Manufacturers Enter into Intravenous Solutions Market
 Table 26. Manufacturers Intravenous Solutions Product Type and Application
 Table 27. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 28. Baxter Company Information
 Table 29. Baxter Description and Business Overview
 Table 30. Baxter Intravenous Solutions Product
 Table 31. Baxter Intravenous Solutions Sales (M Units), Revenue (US$ Million), Price (USD/K Unit) and Gross Margin (2020-2025)
 Table 32. Baxter Sales Proportion of Intravenous Solutions by Product in 2024
 Table 33. Baxter Sales Proportion of Intravenous Solutions by Application in 2024
 Table 34. Baxter Sales Proportion of Intravenous Solutions by Geographic Area in 2024
 Table 35. Baxter Recent Developments
 Table 36. Kelun Group Company Information
 Table 37. Kelun Group Description and Business Overview
 Table 38. Kelun Group Intravenous Solutions Product
 Table 39. Kelun Group Intravenous Solutions Sales (M Units), Revenue (US$ Million), Price (USD/K Unit) and Gross Margin (2020-2025)
 Table 40. Kelun Group Sales Proportion of Intravenous Solutions by Product in 2024
 Table 41. Kelun Group Sales Proportion of Intravenous Solutions by Application in 2024
 Table 42. Kelun Group Sales Proportion of Intravenous Solutions by Geographic Area in 2024
 Table 43. Kelun Group Recent Developments
 Table 44. Fresenius Kabi Company Information
 Table 45. Fresenius Kabi Description and Business Overview
 Table 46. Fresenius Kabi Intravenous Solutions Product
 Table 47. Fresenius Kabi Intravenous Solutions Sales (M Units), Revenue (US$ Million), Price (USD/K Unit) and Gross Margin (2020-2025)
 Table 48. Fresenius Kabi Sales Proportion of Intravenous Solutions by Product in 2024
 Table 49. Fresenius Kabi Sales Proportion of Intravenous Solutions by Application in 2024
 Table 50. Fresenius Kabi Sales Proportion of Intravenous Solutions by Geographic Area in 2024
 Table 51. Fresenius Kabi Recent Developments
 Table 52. Otsuka Company Information
 Table 53. Otsuka Description and Business Overview
 Table 54. Otsuka Intravenous Solutions Product
 Table 55. Otsuka Intravenous Solutions Sales (M Units), Revenue (US$ Million), Price (USD/K Unit) and Gross Margin (2020-2025)
 Table 56. Otsuka Sales Proportion of Intravenous Solutions by Product in 2024
 Table 57. Otsuka Sales Proportion of Intravenous Solutions by Application in 2024
 Table 58. Otsuka Sales Proportion of Intravenous Solutions by Geographic Area in 2024
 Table 59. Otsuka Recent Developments
 Table 60. ICU Medical Company Information
 Table 61. ICU Medical Description and Business Overview
 Table 62. ICU Medical Intravenous Solutions Product
 Table 63. ICU Medical Intravenous Solutions Sales (M Units), Revenue (US$ Million), Price (USD/K Unit) and Gross Margin (2020-2025)
 Table 64. ICU Medical Sales Proportion of Intravenous Solutions by Product in 2024
 Table 65. ICU Medical Sales Proportion of Intravenous Solutions by Application in 2024
 Table 66. ICU Medical Sales Proportion of Intravenous Solutions by Geographic Area in 2024
 Table 67. ICU Medical Recent Developments
 Table 68. Fresenius Kabi Company Information
 Table 69. Fresenius Kabi Description and Business Overview
 Table 70. Fresenius Kabi Intravenous Solutions Product
 Table 71. Fresenius Kabi Intravenous Solutions Sales (M Units), Revenue (US$ Million), Price (USD/K Unit) and Gross Margin (2020-2025)
 Table 72. Fresenius Kabi Sales Proportion of Intravenous Solutions by Product in 2024
 Table 73. Fresenius Kabi Sales Proportion of Intravenous Solutions by Application in 2024
 Table 74. Fresenius Kabi Sales Proportion of Intravenous Solutions by Geographic Area in 2024
 Table 75. Fresenius Kabi Recent Developments
 Table 76. JW Life Science Company Information
 Table 77. JW Life Science Description and Business Overview
 Table 78. JW Life Science Intravenous Solutions Product
 Table 79. JW Life Science Intravenous Solutions Sales (M Units), Revenue (US$ Million), Price (USD/K Unit) and Gross Margin (2020-2025)
 Table 80. JW Life Science Sales Proportion of Intravenous Solutions by Product in 2024
 Table 81. JW Life Science Sales Proportion of Intravenous Solutions by Application in 2024
 Table 82. JW Life Science Sales Proportion of Intravenous Solutions by Geographic Area in 2024
 Table 83. JW Life Science Recent Developments
 Table 84. B. Braun Melsungen Company Information
 Table 85. B. Braun Melsungen Description and Business Overview
 Table 86. B. Braun Melsungen Intravenous Solutions Product
 Table 87. B. Braun Melsungen Intravenous Solutions Sales (M Units), Revenue (US$ Million), Price (USD/K Unit) and Gross Margin (2020-2025)
 Table 88. B. Braun Melsungen Sales Proportion of Intravenous Solutions by Product in 2024
 Table 89. B. Braun Melsungen Sales Proportion of Intravenous Solutions by Application in 2024
 Table 90. B. Braun Melsungen Sales Proportion of Intravenous Solutions by Geographic Area in 2024
 Table 91. B. Braun Melsungen Recent Developments
 Table 92. North America Intravenous Solutions Sales by Country (2020-2025) & (M Units)
 Table 93. North America Intravenous Solutions Sales by Country (2026-2031) & (M Units)
 Table 94. North America Intravenous Solutions Revenue by Country (2020-2025) & (US$ Million)
 Table 95. North America Intravenous Solutions Revenue by Country (2026-2031) & (US$ Million)
 Table 96. North America Intravenous Solutions Sales by Type (2020-2025) & (M Units)
 Table 97. North America Intravenous Solutions Sales by Application (2020-2025) & (M Units)
 Table 98. Asia-Pacific Intravenous Solutions Sales by Region (2020-2025) & (M Units)
 Table 99. Asia-Pacific Intravenous Solutions Sales by Region (2026-2031) & (M Units)
 Table 100. Asia-Pacific Intravenous Solutions Revenue by Region (2020-2025) & (US$ Million)
 Table 101. Asia-Pacific Intravenous Solutions Revenue by Region (2026-2031) & (US$ Million)
 Table 102. Asia-Pacific Intravenous Solutions Sales by Type (2020-2025) & (M Units)
 Table 103. Asia-Pacific Intravenous Solutions Sales by Application (2020-2025) & (M Units)
 Table 104. Europe Intravenous Solutions Sales by Country (2020-2025) & (M Units)
 Table 105. Europe Intravenous Solutions Sales by Country (2026-2031) & (M Units)
 Table 106. Europe Intravenous Solutions Revenue by Country (2020-2025) & (US$ Million)
 Table 107. Europe Intravenous Solutions Revenue by Country (2026-2031) & (US$ Million)
 Table 108. Europe Intravenous Solutions Sales by Type (2020-2025) & (M Units)
 Table 109. Europe Intravenous Solutions Sales by Application (2020-2025) & (M Units)
 Table 110. Latin America Intravenous Solutions Sales by Country (2020-2025) & (M Units)
 Table 111. Latin America Intravenous Solutions Sales by Country (2026-2031) & (M Units)
 Table 112. Latin America Intravenous Solutions Revenue by Country (2020-2025) & (US$ Million)
 Table 113. Latin America Intravenous Solutions Revenue by Country (2026-2031) & (US$ Million)
 Table 114. Latin America Intravenous Solutions Sales by Type (2020-2025) & (M Units)
 Table 115. Latin America Intravenous Solutions Sales by Application (2020-2025) & (M Units)
 Table 116. Middle East and Africa Intravenous Solutions Sales by Country (2020-2025) & (M Units)
 Table 117. Middle East and Africa Intravenous Solutions Sales by Country (2026-2031) & (M Units)
 Table 118. Middle East and Africa Intravenous Solutions Revenue by Country (2020-2025) & (US$ Million)
 Table 119. Middle East and Africa Intravenous Solutions Revenue by Country (2026-2031) & (US$ Million)
 Table 120. Middle East and Africa Intravenous Solutions Sales by Type (2020-2025) & (M Units)
 Table 121. Middle East and Africa Intravenous Solutions Sales by Application (2020-2025) & (M Units)
 Table 122. Intravenous Solutions Key Raw Materials, Industry Status and Trend
 Table 123. Intravenous Solutions Key Raw Materials and Upstream Suppliers
 Table 124. Intravenous Solutions Clients Status and Trend
 Table 125. Intravenous Solutions Typical Clients
 Table 126. Intravenous Solutions Distributors
 Table 127. Intravenous Solutions Market Trends
 Table 128. Intravenous Solutions Market Drivers
 Table 129. Intravenous Solutions Market Challenges
 Table 130. Intravenous Solutions Market Restraints
 Table 131. Research Programs/Design for This Report
 Table 132. Key Data Information from Secondary Sources
 Table 133. Key Data Information from Primary Sources
 Table 134. QYR Business Unit and Senior & Team Lead Analysts


List of Figures
 Figure 1. Intravenous Solutions Product Picture
 Figure 2. Global Intravenous Solutions Market Size by Type (US$ Million): 2020 VS 2024 VS 2031
 Figure 3. Global Intravenous Solutions Sales Market Share by Type in 2024 & 2031
 Figure 4. Crystalloids Product Picture
 Figure 5. Colloids Product Picture
 Figure 6. Others Product Picture
 Figure 7. Global Intravenous Solutions Market Size by Application (US$ Million): 2020 VS 2024 VS 2031
 Figure 8. Global Intravenous Solutions Sales Market Share by Application in 2024 & 2031
 Figure 9. Basic IV Solutions
 Figure 10. Nutrient Infusion Solution
 Figure 11. Others
 Figure 12. Intravenous Solutions Report Years Considered
 Figure 13. Global Intravenous Solutions Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 14. Global Intravenous Solutions Market Size 2020-2031 (US$ Million)
 Figure 15. Global Intravenous Solutions Sales 2020-2031 (M Units)
 Figure 16. Global Intravenous Solutions Sales Market Share Forecast by Region (2020-2031)
 Figure 17. Global Intravenous Solutions Revenue Market Share by Region (2020-2031)
 Figure 18. Global Intravenous Solutions Sales Market Share Forecast by Type (2020-2031)
 Figure 19. Global Intravenous Solutions Revenue Market Share Forecast by Type (2020-2031)
 Figure 20. Intravenous Solutions Average Selling Price (ASP) by Type (2020-2025) & (USD/K Unit)
 Figure 21. Global Intravenous Solutions Sales Market Share Forecast by Application (2020-2031)
 Figure 22. Global Intravenous Solutions Revenue Market Share Forecast by Application (2020-2031)
 Figure 23. Intravenous Solutions Average Selling Price (ASP) by Application (2020-2025) & (USD/K Unit)
 Figure 24. Crystalloids of Intravenous Solutions Revenue Market Share by Application, 2024 VS 2031
 Figure 25. Colloids of Intravenous Solutions Revenue Market Share by Application, 2024 VS 2031
 Figure 26. Others of Intravenous Solutions Revenue Market Share by Application, 2024 VS 2031
 Figure 27. Global Intravenous Solutions Sales Share by Manufacturer in 2024
 Figure 28. Intravenous Solutions Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 29. Crystalloids Market Sales Proportion by Manufacturer in 2024
 Figure 30. Colloids Market Sales Proportion by Manufacturer in 2024
 Figure 31. Others Market Sales Proportion by Manufacturer in 2024
 Figure 32. North America Intravenous Solutions Revenue 2020-2031 (US$ Million)
 Figure 33. North America Intravenous Solutions Sales Market Share by Type (2020-2025)
 Figure 34. North America Intravenous Solutions Sales Market Share by Application (2020-2025)
 Figure 35. Asia-Pacific Intravenous Solutions Revenue 2020-2031 (US$ Million)
 Figure 36. Asia-Pacific Intravenous Solutions Sales Market Share by Region (2020-2031)
 Figure 37. Asia-Pacific Intravenous Solutions Revenue Market Share by Region (2020-2031)
 Figure 38. Asia-Pacific Intravenous Solutions Sales Market Share by Type (2020-2025)
 Figure 39. Asia-Pacific Intravenous Solutions Sales Market Share by Application (2020-2025)
 Figure 40. Europe Intravenous Solutions Revenue Growth Rate 2020-2031 (US$ Million)
 Figure 41. Europe Intravenous Solutions Sales Market Share by Country (2020-2031)
 Figure 42. Europe Intravenous Solutions Revenue Market Share by Country (2020-2031)
 Figure 43. Europe Intravenous Solutions Sales Market Share by Type (2020-2025)
 Figure 44. Europe Intravenous Solutions Sales Market Share by Application (2020-2025)
 Figure 45. Latin America Intravenous Solutions Revenue Growth Rate 2020-2031 (US$ Million)
 Figure 46. Latin America Intravenous Solutions Sales Market Share by Country (2020-2031)
 Figure 47. Latin America Intravenous Solutions Revenue Market Share by Country (2020-2025)
 Figure 48. Latin America Intravenous Solutions Sales Market Share by Type (2020-2025)
 Figure 49. Latin America Intravenous Solutions Sales Market Share by Application (2020-2025)
 Figure 50. Middle East and Africa Intravenous Solutions Revenue Growth Rate 2020-2031 (US$ Million)
 Figure 51. Middle East and Africa Intravenous Solutions Sales Market Share by Country (2020-2031)
 Figure 52. Middle East and Africa Intravenous Solutions Revenue Market Share by Country (2020-2031)
 Figure 53. Middle East and Africa Intravenous Solutions Sales Market Share by Type (2020-2025)
 Figure 54. Middle East and Africa Intravenous Solutions Sales Market Share by Application (2020-2025)
 Figure 55. Intravenous Solutions Supply Chain (Upstream and Downstream Market)
 Figure 56. Global Production Market Share of Intravenous Solutions Raw Materials by Region in 2024
 Figure 57. Intravenous Solutions Distribution Channels
 Figure 58. Global Intravenous Solutions Percentage 2020-2031: Indirect Sales VS Direct Sales
 Figure 59. Global Intravenous Solutions Percentage 2020-2031: Online Sales VS Offline Sales
 Figure 60. Bottom-up and Top-down Approaches for This Report
 Figure 61. Data Triangulation
 Figure 62. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$5900

This license allows only one user to access the PDF.
Electronic (PDF)

$8850

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$11800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Novocure